Table 2.
Baseline (n = 62) | Follow‐Up (n = 45) | |||
---|---|---|---|---|
cT1 | cT1 IQR | cT1 | cT1 IQR | |
Correlation with serum liver and liver function tests | ||||
Platelets | −0.09 | −0.40 | 0.17 | −0.29 |
P = 0.499 | P = 0.001 | P = 0.281 | P = 0.054 | |
ALT | 0.28 | 0.18 | 0.41 | 0.08 |
P = 0.028 | P = 0.171 | P = 0.005 | P = 0.594 | |
AST | 0.26 | 0.37 | 0.45 | −0.05 |
P = 0.038 | P = 0.003 | P = 0.002 | P = 0.736 | |
Bilirubin | 0.17 | 0.49 | −0.18 | −0.07 |
P = 0.180 | P < 0.001 | P = 0.237 | P = 0.653 | |
IgG | 0.25 | 0.19 | 0.22 | 0.27 |
P = 0.055 | P = 0.131 | P = 0.139 | P = 0.074 | |
Correlation with surrogate disease severity markers | ||||
LS (n = 61) | 0.51 | 0.52 | 0.38 | 0.23 |
P < 0.001 | P < 0.001 | P = 0.010 | P = 0.127 | |
APRI | 0.24 | 0.46 | 0.15 | 0.19 |
P = 0.058 | P < 0.001 | P = 0.327 | P = 0.207 | |
MELD | 0.32 | 0.23 | 0.27 | −0.12 |
P = 0.010 | P = 0.076 | P = 0.076 | P = 0.432 | |
ELF | 0.29 | 0.20 | 0.29 | −0.06 |
P = 0.022 | P = 0.128 | P = 0.070 | P = 0.729 | |
INR | 0.35 | 0.22 | 0.29 | −0.08 |
P = 0.005 | P = 0.081 | P = 0.052 | P = 0.606 |
P < 0.05 is considered statistically significant.